New α- and γ-synuclein immunopathological lesions in human brain

Table 1 The amount of oxi- Met ³ - γ-synuclein –positive astrocytes in patients with NDDs and control individuals

Patient's ID	Sex	Age	Diagnosis	Number of oxi-Met³⁸-γ-syn–positive astrocytes
K33	M	76	DLB	+
K11	F	87	AD with DLB related pathology	+
K13	M	85	DLB	++
K39	M	74	DLB	+
S3	M	73	DLB + mild AD	+++
S4	F	87	AD with DLB related pathology	++
PD1	M	55	PD	++
PD2	M	85	PD	++++
K21	M	97	Control	++
K35	F	61	Control	+
K41	F	61	Control	++
K45	M	66	Control	+
K46	M	79	Control	+++
K48	F	88	Control	+++

The patients were selected based on the neuropathological characteristics. The number of oxi-Met³⁸ –positive astrocytes was calculated on a 2 x 2.5 cm slice.
+ represents the number of oxi-Met³⁸ –positive astrocytes from 1 to 2.
++ represent the number of oxi-Met³⁸ –positive astrocytes from 2 to 5.
+++ represent the number of oxi-Met38 –positive astrocytes from 5 to10.
++++ represent the number of oxi-Met38 –positive astrocytes > 10.

ISSN: 2051-5960